{"entity":{"type":"insider","cik":"0001465825","url":"/insider/0001465825","json_url":"/insider/0001465825.json","name":"NIGALAYE ASHOK G","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":28,"n_filings":18,"first":"2011-03-17","last":"2014-03-17","span_basis":"filed_date"},"name_variants":[{"name":"NIGALAYE ASHOK G","source":"filing","n_filings":18,"first_seen":"2011-03-17","last_seen":"2014-03-17"}],"transactions":[{"id":6249779,"accession":"0001053369-14-000026","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-14-000026","line_url":"/filing/0001053369-14-000026#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465825","owner_name":"NIGALAYE ASHOK G","owner_display_name":"NIGALAYE ASHOK G","owner_url":"/insider/0001465825","role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":239367.0,"shares_display":"239,367","price_per_share":0.6016,"price_display":"0.60","price_state":"stated","total_value":144003.1872,"total_display":"144,003.19","total_whole":"144,003","shares_owned_after":20300770.0,"shares_owned_after_display":"20,300,770","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-03-11","filed_date":"2014-03-17","scope":"insider"},{"id":6921159,"accession":"0001465826-14-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001465826-14-000003","line_url":"/filing/0001465826-14-000003#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465825","owner_name":"NIGALAYE ASHOK G","owner_display_name":"NIGALAYE ASHOK G","owner_url":"/insider/0001465825","role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1051450.0,"shares_display":"1,051,450","price_per_share":0.68,"price_display":"0.68","price_state":"stated","total_value":714986.0,"total_display":"714,986.00","total_whole":"714,986","shares_owned_after":20372580.0,"shares_owned_after_display":"20,372,580","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-03-07","filed_date":"2014-03-10","scope":"insider"},{"id":6921156,"accession":"0001465826-14-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001465826-14-000003","line_url":"/filing/0001465826-14-000003#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465825","owner_name":"NIGALAYE ASHOK G","owner_display_name":"NIGALAYE ASHOK G","owner_url":"/insider/0001465825","role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":773050.0,"shares_display":"773,050","price_per_share":0.8956,"price_display":"0.90","price_state":"stated","total_value":692343.58,"total_display":"692,343.58","total_whole":"692,344","shares_owned_after":20688015.0,"shares_owned_after_display":"20,688,015","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-03-06","filed_date":"2014-03-10","scope":"insider"},{"id":6394486,"accession":"0001053369-14-000013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-14-000013","line_url":"/filing/0001053369-14-000013#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465825","owner_name":"NIGALAYE ASHOK G","owner_display_name":"NIGALAYE ASHOK G","owner_url":"/insider/0001465825","role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":805583.0,"shares_display":"805,583","price_per_share":0.183,"price_display":"0.18","price_state":"stated","total_value":147421.689,"total_display":"147,421.69","total_whole":"147,422","shares_owned_after":20919930.0,"shares_owned_after_display":"20,919,930","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-01-13","filed_date":"2014-01-17","scope":"insider"},{"id":4697836,"accession":"0001442002-13-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001442002-13-000002","line_url":"/filing/0001442002-13-000002#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465825","owner_name":"NIGALAYE ASHOK G","owner_display_name":"NIGALAYE ASHOK G","owner_url":"/insider/0001465825","role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":275000.0,"shares_display":"275,000","price_per_share":0.1255,"price_display":"0.13","price_state":"stated","total_value":34512.5,"total_display":"34,512.50","total_whole":"34,513","shares_owned_after":21301460.0,"shares_owned_after_display":"21,301,460","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-12-05","filed_date":"2013-12-13","scope":"insider"},{"id":4517806,"accession":"0001053369-13-000061","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-13-000061","line_url":"/filing/0001053369-13-000061#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465825","owner_name":"NIGALAYE ASHOK G","owner_display_name":"NIGALAYE ASHOK G","owner_url":"/insider/0001465825","role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":0.1252,"price_display":"0.13","price_state":"stated","total_value":12520.0,"total_display":"12,520.00","total_whole":"12,520","shares_owned_after":21391048.0,"shares_owned_after_display":"21,391,048","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-12-02","filed_date":"2013-12-04","scope":"insider"},{"id":4485651,"accession":"0001053369-13-000057","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001053369-13-000057","line_url":"/filing/0001053369-13-000057#line-3","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465825","owner_name":"NIGALAYE ASHOK G","owner_display_name":"NIGALAYE ASHOK G","owner_url":"/insider/0001465825","role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":0.1212,"price_display":"0.12","price_state":"stated","total_value":3030.0,"total_display":"3,030.00","total_whole":"3,030","shares_owned_after":21421048.0,"shares_owned_after_display":"21,421,048","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-27","filed_date":"2013-11-29","scope":"insider"},{"id":4697831,"accession":"0001442002-13-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001442002-13-000002","line_url":"/filing/0001442002-13-000002#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465825","owner_name":"NIGALAYE ASHOK G","owner_display_name":"NIGALAYE ASHOK G","owner_url":"/insider/0001465825","role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23626.0,"shares_display":"23,626","price_per_share":0.1182,"price_display":"0.12","price_state":"stated","total_value":2792.5932,"total_display":"2,792.59","total_whole":"2,793","shares_owned_after":21383960.0,"shares_owned_after_display":"21,383,960","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-26","filed_date":"2013-12-13","scope":"insider"},{"id":4485643,"accession":"0001053369-13-000057","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001053369-13-000057","line_url":"/filing/0001053369-13-000057#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465825","owner_name":"NIGALAYE ASHOK G","owner_display_name":"NIGALAYE ASHOK G","owner_url":"/insider/0001465825","role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":357000.0,"shares_display":"357,000","price_per_share":0.1208,"price_display":"0.12","price_state":"stated","total_value":43125.6,"total_display":"43,125.60","total_whole":"43,126","shares_owned_after":21428528.0,"shares_owned_after_display":"21,428,528","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-26","filed_date":"2013-11-29","scope":"insider"},{"id":5377964,"accession":"0001465826-13-000003","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001465826-13-000003","line_url":"/filing/0001465826-13-000003#line-4","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465825","owner_name":"NIGALAYE ASHOK G","owner_display_name":"NIGALAYE ASHOK G","owner_url":"/insider/0001465825","role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21000.0,"shares_display":"21,000","price_per_share":0.117,"price_display":"0.12","price_state":"stated","total_value":2457.0,"total_display":"2,457.00","total_whole":"2,457","shares_owned_after":21547348.0,"shares_owned_after_display":"21,547,348","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-19","filed_date":"2013-11-19","scope":"insider"},{"id":5377960,"accession":"0001465826-13-000003","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001465826-13-000003","line_url":"/filing/0001465826-13-000003#line-3","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465825","owner_name":"NIGALAYE ASHOK G","owner_display_name":"NIGALAYE ASHOK G","owner_url":"/insider/0001465825","role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1170000.0,"shares_display":"1,170,000","price_per_share":0.1175,"price_display":"0.12","price_state":"stated","total_value":137475.0,"total_display":"137,475.00","total_whole":"137,475","shares_owned_after":21553648.0,"shares_owned_after_display":"21,553,648","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-18","filed_date":"2013-11-19","scope":"insider"},{"id":9218464,"accession":"0001053369-14-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-14-000003","line_url":"/filing/0001053369-14-000003#line-1","is_derivative":false,"issuer_cik":"0001465825","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001465825","owner_cik":"0001465825","owner_name":"NIGALAYE ASHOK G","owner_display_name":"NIGALAYE ASHOK G","owner_url":"/insider/0001465825","role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":253050.0,"shares_display":"253,050","price_per_share":0.1173,"price_display":"0.12","price_state":"stated","total_value":29682.765,"total_display":"29,682.76","total_whole":"29,683","shares_owned_after":21885148.0,"shares_owned_after_display":"21,885,148","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-15","filed_date":"2014-01-06","scope":"insider"},{"id":5377959,"accession":"0001465826-13-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001465826-13-000003","line_url":"/filing/0001465826-13-000003#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465825","owner_name":"NIGALAYE ASHOK G","owner_display_name":"NIGALAYE ASHOK G","owner_url":"/insider/0001465825","role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":318050.0,"shares_display":"318,050","price_per_share":0.1173,"price_display":"0.12","price_state":"stated","total_value":37307.265,"total_display":"37,307.26","total_whole":"37,307","shares_owned_after":24095113.0,"shares_owned_after_display":"24,095,113","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-15","filed_date":"2013-11-19","scope":"insider"},{"id":5377958,"accession":"0001465826-13-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001465826-13-000003","line_url":"/filing/0001465826-13-000003#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465825","owner_name":"NIGALAYE ASHOK G","owner_display_name":"NIGALAYE ASHOK G","owner_url":"/insider/0001465825","role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":465090.0,"shares_display":"465,090","price_per_share":0.1152,"price_display":"0.12","price_state":"stated","total_value":53578.368,"total_display":"53,578.37","total_whole":"53,578","shares_owned_after":24200069.0,"shares_owned_after_display":"24,200,069","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-14","filed_date":"2013-11-19","scope":"insider"},{"id":4485637,"accession":"0001053369-13-000057","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-13-000057","line_url":"/filing/0001053369-13-000057#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465825","owner_name":"NIGALAYE ASHOK G","owner_display_name":"NIGALAYE ASHOK G","owner_url":"/insider/0001465825","role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39000.0,"shares_display":"39,000","price_per_share":0.1225,"price_display":"0.12","price_state":"stated","total_value":4777.5,"total_display":"4,777.50","total_whole":"4,778","shares_owned_after":21535048.0,"shares_owned_after_display":"21,535,048","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-11","filed_date":"2013-11-29","scope":"insider"},{"id":4485631,"accession":"0001053369-13-000053","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-13-000053","line_url":"/filing/0001053369-13-000053#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465825","owner_name":"NIGALAYE ASHOK G","owner_display_name":"NIGALAYE ASHOK G","owner_url":"/insider/0001465825","role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":122200.0,"shares_display":"122,200","price_per_share":0.1235,"price_display":"0.12","price_state":"stated","total_value":15091.7,"total_display":"15,091.70","total_whole":"15,092","shares_owned_after":22139590.0,"shares_owned_after_display":"22,139,590","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-06","filed_date":"2013-11-08","scope":"insider"},{"id":4669331,"accession":"0001053369-13-000049","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001053369-13-000049","line_url":"/filing/0001053369-13-000049#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465825","owner_name":"NIGALAYE ASHOK G","owner_display_name":"NIGALAYE ASHOK G","owner_url":"/insider/0001465825","role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":139800.0,"shares_display":"139,800","price_per_share":0.127,"price_display":"0.13","price_state":"stated","total_value":17754.6,"total_display":"17,754.60","total_whole":"17,755","shares_owned_after":22176250.0,"shares_owned_after_display":"22,176,250","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-29","filed_date":"2013-10-30","scope":"insider"},{"id":4669325,"accession":"0001053369-13-000049","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-13-000049","line_url":"/filing/0001053369-13-000049#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465825","owner_name":"NIGALAYE ASHOK G","owner_display_name":"NIGALAYE ASHOK G","owner_url":"/insider/0001465825","role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":139500.0,"shares_display":"139,500","price_per_share":0.1295,"price_display":"0.13","price_state":"stated","total_value":18065.25,"total_display":"18,065.25","total_whole":"18,065","shares_owned_after":22316050.0,"shares_owned_after_display":"22,316,050","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-28","filed_date":"2013-10-30","scope":"insider"},{"id":5557278,"accession":"0001053369-13-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-13-000012","line_url":"/filing/0001053369-13-000012#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465825","owner_name":"NIGALAYE ASHOK G","owner_display_name":"NIGALAYE ASHOK G","owner_url":"/insider/0001465825","role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":356700.0,"shares_display":"356,700","price_per_share":0.09,"price_display":"0.09","price_state":"stated","total_value":32103.0,"total_display":"32,103.00","total_whole":"32,103","shares_owned_after":13303884.0,"shares_owned_after_display":"13,303,884","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-01-22","filed_date":"2013-01-25","scope":"insider"},{"id":4630701,"accession":"0001053369-13-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-13-000003","line_url":"/filing/0001053369-13-000003#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465825","owner_name":"NIGALAYE ASHOK G","owner_display_name":"NIGALAYE ASHOK G","owner_url":"/insider/0001465825","role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2339000.0,"shares_display":"2,339,000","price_per_share":0.0906,"price_display":"0.09","price_state":"stated","total_value":211913.4,"total_display":"211,913.40","total_whole":"211,913","shares_owned_after":7628584.0,"shares_owned_after_display":"7,628,584","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-01-11","filed_date":"2013-01-14","scope":"insider"},{"id":6757001,"accession":"0001053369-14-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-14-000009","line_url":"/filing/0001053369-14-000009#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465825","owner_name":"NIGALAYE ASHOK G","owner_display_name":"NIGALAYE ASHOK G","owner_url":"/insider/0001465825","role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":531185.0,"shares_display":"531,185","price_per_share":0.15,"price_display":"0.15","price_state":"stated","total_value":79677.75,"total_display":"79,677.75","total_whole":"79,678","shares_owned_after":21161605.0,"shares_owned_after_display":"21,161,605","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-01-03","filed_date":"2014-01-07","scope":"insider"},{"id":3333623,"accession":"0001053369-12-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-12-000011","line_url":"/filing/0001053369-12-000011#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465825","owner_name":"NIGALAYE ASHOK G","owner_display_name":"NIGALAYE ASHOK G","owner_url":"/insider/0001465825","role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":561000.0,"shares_display":"561,000","price_per_share":0.0907,"price_display":"0.09","price_state":"stated","total_value":50882.7,"total_display":"50,882.70","total_whole":"50,883","shares_owned_after":9967584.0,"shares_owned_after_display":"9,967,584","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-12-26","filed_date":"2012-12-31","scope":"insider"},{"id":2480856,"accession":"0001053369-12-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-12-000007","line_url":"/filing/0001053369-12-000007#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465825","owner_name":"NIGALAYE ASHOK G","owner_display_name":"NIGALAYE ASHOK G","owner_url":"/insider/0001465825","role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":243300.0,"shares_display":"243,300","price_per_share":0.0918,"price_display":"0.09","price_state":"stated","total_value":22334.94,"total_display":"22,334.94","total_whole":"22,335","shares_owned_after":27534004.0,"shares_owned_after_display":"27,534,004","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-12-19","filed_date":"2012-12-21","scope":"insider"},{"id":3402495,"accession":"0001345568-12-000024","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001345568-12-000024","line_url":"/filing/0001345568-12-000024#line-3","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465825","owner_name":"NIGALAYE ASHOK G","owner_display_name":"NIGALAYE ASHOK G","owner_url":"/insider/0001465825","role":"Director, Officer (Chief Financial Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":735000.0,"shares_display":"735,000","price_per_share":0.09,"price_display":"0.09","price_state":"stated","total_value":66150.0,"total_display":"66,150.00","total_whole":"66,150","shares_owned_after":61273251.0,"shares_owned_after_display":"61,273,251","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-03-27","filed_date":"2012-03-27","scope":"insider"},{"id":3402493,"accession":"0001345568-12-000024","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001345568-12-000024","line_url":"/filing/0001345568-12-000024#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465825","owner_name":"NIGALAYE ASHOK G","owner_display_name":"NIGALAYE ASHOK G","owner_url":"/insider/0001465825","role":"Director, Officer (Chief Financial Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":225000.0,"shares_display":"225,000","price_per_share":0.0947,"price_display":"0.09","price_state":"stated","total_value":21307.5,"total_display":"21,307.50","total_whole":"21,308","shares_owned_after":62008251.0,"shares_owned_after_display":"62,008,251","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-03-26","filed_date":"2012-03-27","scope":"insider"},{"id":3402491,"accession":"0001345568-12-000024","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001345568-12-000024","line_url":"/filing/0001345568-12-000024#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465825","owner_name":"NIGALAYE ASHOK G","owner_display_name":"NIGALAYE ASHOK G","owner_url":"/insider/0001465825","role":"Director, Officer (Chief Financial Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1765000.0,"shares_display":"1,765,000","price_per_share":0.0958,"price_display":"0.10","price_state":"stated","total_value":169087.0,"total_display":"169,087.00","total_whole":"169,087","shares_owned_after":62233251.0,"shares_owned_after_display":"62,233,251","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-03-23","filed_date":"2012-03-27","scope":"insider"},{"id":3444224,"accession":"0001345568-12-000011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001345568-12-000011","line_url":"/filing/0001345568-12-000011#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465825","owner_name":"NIGALAYE ASHOK G","owner_display_name":"NIGALAYE ASHOK G","owner_url":"/insider/0001465825","role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":85000.0,"shares_display":"85,000","price_per_share":0.1005,"price_display":"0.10","price_state":"stated","total_value":8542.5,"total_display":"8,542.50","total_whole":"8,543","shares_owned_after":63766618.0,"shares_owned_after_display":"63,766,618","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-03-16","filed_date":"2012-03-20","scope":"insider"},{"id":9173175,"accession":"0001465825-11-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001465825-11-000002","line_url":"/filing/0001465825-11-000002#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465825","owner_name":"NIGALAYE ASHOK G","owner_display_name":"NIGALAYE ASHOK G","owner_url":"/insider/0001465825","role":"Director, Officer (Chief Scientific Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":407949.0,"shares_display":"407,949","price_per_share":0.04,"price_display":"0.04","price_state":"stated","total_value":16317.96,"total_display":"16,317.96","total_whole":"16,318","shares_owned_after":407949.0,"shares_owned_after_display":"407,949","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-02","filed_date":"2011-03-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":28,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":27,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":28},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001053369","name":"ELITE PHARMACEUTICALS INC /NV/","url":"/issuer/0001053369","role":"Director, Officer (Chief Scientific Officer), Ten percent owner","n_filings":18,"first_seen":"2011-03-17","last_seen":"2014-03-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001465825","retrieved_at":"2026-08-23T08:41:20+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}